hiv-aids

Documents about hiv-aids

• SSAT063- Pharmacokinetics of Efavirenz 400 mg Once Daily During Pregnancy in HIV-1 Infected Women#991901ClinicalTrials.gov
• Peer-Driven Intervention to Enroll Minorities/Women in HIV/AIDS Clinical Trials (the ACT2 Project)#992428ClinicalTrials.gov
• PREPARE (A5361s) Ancillary Study of REPRIEVE (A5332)#1008405ClinicalTrials.gov
• A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)#869163ClinicalTrials.gov
• Phase 1 Safety Study of Two Experimental HIV Vaccines#806647ClinicalTrials.gov
• A Prospective Observational Trial to Determine Cardiovascular Diseases in HIV-infected Patients#893918ClinicalTrials.gov
• Safety and Immunogenicity of TBC-M4, a MVA HIV Vaccine Alone or in a Prime-Boost Regimen With ADVAX DNA HIV Vaccine#136433ClinicalTrials.gov
• Improving Maternal heAlth by Reducing Malaria in African HIV Women#806629ClinicalTrials.gov
• Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*#850147ClinicalTrials.gov
• Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV#858552ClinicalTrials.gov
• Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults#909819ClinicalTrials.gov
• Same-Day Restart of B/F/TAF in HIV Patients After NNRTI Discontinuation#968069ClinicalTrials.gov
• Healthy Teen Girls: HIV Risk Reduction#1008505ClinicalTrials.gov
• Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML)#857596ClinicalTrials.gov
• Data for: Perceptions of stigma and discrimination in health care settings towards Sub-saharan African migrant women living with hiv/aids in Belgium: A qualitative study#939467QDR Main Collection Dataverse OAI Archive
• Gaps in HIV testing for children of mothers with known HIV positive status: Results from Population-based HIV Impact Assessments (PHIA) in Sub-Saharan Africa (2015-2019)#68010bioRxiv / medRxiv
• A Phase IIA Trial to Evaluate the Safety and Immunogenicity of a DNA HIV-1 Vaccine Followed by an MVA HIV-1 Vaccine in HIV-uninfected Volunteers#311201ClinicalTrials.gov
• Peripheral Stem Cell Transplantation Followed By Infusion of White Blood Cells in Treating Patients With AIDS-Related Lymphoma#812763ClinicalTrials.gov
• AIDS Wasting in Women: Anabolic Effects of Testosterone#901472ClinicalTrials.gov
• Depot Disulfiram for AIDS and ARC#969141ClinicalTrials.gov
• Can Undetectable (Viral Load) = Untransmissible (Virus) Change the Life Course of Adolescents Living in Africa#893004ClinicalTrials.gov
• Abacavir Pharmacokinetic Study in the Absence/Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected Subjects#860131ClinicalTrials.gov
• Guidelines for the clinical management of HIV infection in adults#470963WHO IRIS
• The Effects of a Supervised Exercise Program on Self Efficacy of People Living With HIV/AIDS.#805651ClinicalTrials.gov
• Smoking Cessation Pilot for People Living With HIV (PLWH)#866997ClinicalTrials.gov
• A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy#897454ClinicalTrials.gov
• ART-CHESS: A Mobile Health Application to Support People Living With HIV and Addiction#966930ClinicalTrials.gov
• Incidence of Oral Candidiasis, Prevalence of C. Dubliniensis in HIV Patients and In-vitro Azole Susceptibility#1030384ClinicalTrials.gov
• Penyuluhan Pencegahan HIV/AIDS bagi Pelajar SMU di Kota Banjarmasin#677791IPB Scientific Repository
• Differentiated Service Delivery for Antiretroviral Therapy#805710ClinicalTrials.gov
• Optimizing mHealth for Adherence Monitoring and Intervention#982303ClinicalTrials.gov
• Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years.#321545ClinicalTrials.gov
• 22 U.S.C. § 7612 — HIV/AIDS response Coordinator#578032US Code (LII)
• Integration of HIV Care and Treatment Into Antenatal Care in Migori District, Kenya#847185ClinicalTrials.gov
• Study of HIV, HCV, APS and Phylogenetics for PWID#852470ClinicalTrials.gov
• Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC#834990ClinicalTrials.gov
• A Phase I/II Safety and Immunogenicity Trial of UBI Microparticulate Monovalent (HIV-1 MN) Branched Peptide Vaccine in HIV-1 Seronegative Human Subjects#855639ClinicalTrials.gov
• A Randomized Trial of IUD Versus Hormonal Contraception in HIV-infected Women in Zambia#857550ClinicalTrials.gov
• Endothelial Function, Lipoproteins, and Inflammation With Low HDL Cholesterol in HIV: ER Niacin Versus Fenofibrate#885536ClinicalTrials.gov
• Human Papilloma Virus Infection in HIV-Positive Indian Men Who Have Sex With Men#1010055ClinicalTrials.gov
• Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal Tissue#1010311ClinicalTrials.gov
• Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis#888605ClinicalTrials.gov
• Time to First-Line Antiretroviral Therapy Failure and Its Predictors among People Living with HIV in Tanzania#13878bioRxiv / medRxiv
• A Trial of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine, Administered to Healthy Adults Living Without and With HIV.#429627ClinicalTrials.gov
• Effect of Cenicriviroc on HIV Neurocognitive Impairment#826061ClinicalTrials.gov
• Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations#835035ClinicalTrials.gov
• The PrEP (Pre-exposure Prophylaxis) SMART Study#840881ClinicalTrials.gov
• Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen#841789ClinicalTrials.gov
• REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment#861312ClinicalTrials.gov
• Social Network Intervention to Engage Community PLH to Engage in HIV Medical Care#910696ClinicalTrials.gov